Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial
| Image |  |
|---|---|
| Description | scientific article published on 11 September 2019 |
| Author/s |
author: Benjamin Z Leder |
| Publication date | September 11, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |